63 results
8-K
EX-99.1
NDRA
ENDRA Life Sciences Inc
20 May 24
ENDRA Provides Update Following In-person Meeting with FDA
8:05am
is designed to work in concert with the more than 700,000 ultrasound systems in use globally today. TAEUS® is initially focused on the non-invasive assessment
8-K
EX-99.1
NDRA
ENDRA Life Sciences Inc
14 May 24
ENDRA Life Sciences Reports First Quarter 2024 Financial Results and Provides a Business Update
4:17pm
TAEUS liver system in a clinical study to compare its liver fat assessment accuracy with MRI. This study is expected to include approximately 75
424B5
NDRA
ENDRA Life Sciences Inc
3 Apr 24
Prospectus supplement for primary offering
5:15pm
require the use of expensive CT or MRI imaging systems, where imaging is not practical using existing technology, or where other assessment tools
424B5
3wl3yel
3 Apr 24
Prospectus supplement for primary offering
5:14pm
8-K
EX-99.1
uj5v9
28 Mar 24
ENDRA Life Sciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
4:10pm
8-K
EX-99.1
yd9 0nri6if3
14 Nov 23
ENDRA Life Sciences Reports Third Quarter 2023 Financial Results and Provides Business Update
4:02pm
8-K
EX-99.1
dexpzb0un1x
14 Aug 23
ENDRA Life Sciences Reports Second Quarter 2023 Financial Results and Provides a Business Update
4:13pm
8-K
EX-99.2
wfx10yrb wclt99ls
14 Aug 23
ENDRA Life Sciences Reports Second Quarter 2023 Financial Results and Provides a Business Update
4:13pm
8-K
EX-99.1
oajcckdnc pa
15 May 23
ENDRA Life Sciences Reports First Quarter 2023 Financial Results and Provides a Business Update
12:00am
424B5
at6cp
28 Apr 23
Prospectus supplement for primary offering
4:51pm